By Maggie Fick LONDON Weight-loss drug Wegovy helped Rebecca Vogt achieve a major goal - shedding the weight

'GMA' stars Amy Robach and TJ Holmes professed their love publicy by announcing a joint venture together

Chinese authorities are facing pressure to back up their reassuring rhetoric on the economy with more substantive action.

By Jody Godoy A former FBI agent admitted to working for Russian oligarch Oleg Deripaska while he was

Friday night's Mega Millions jackpot is estimated at $1.25 billion, the fourth-highest ever for the lottery.

The decline of one of the rarest whales in the world appears to be slowing, but scientists warn the giant animals still face existential threats from warming oceans, ship collisions and entanglement in fishing gear

Billionaire Elon Musk reportedly restricted his Starlink internet access multiple times in Ukraine, which has affected Kyiv’s battlefield strategy. The world’s richest man denied the Ukrainian military’s request to turn on Starlink near Crimea, the Russian-controlled territory, during the ongoing war with Russia, the New York Times reported, citing people familiar with the situation. The Tesla CEO has been providing Starlink service to Ukraine since late February 2022, just days after Russian president Vladimir Putin launched his unprovoked invasion and a cyberattack took down the country’s internet. SpaceX’s Starlink makes up the majority of satellites orbiting Earth with more than 4,000 of them in the low-Earth orbit. Mr Musk’s unilateral hold over his satellite internet technology, which has been an essential part of Ukraine's communications since the war, has raised concerns among officials, according to the report. In February this year, SpaceX announced it had taken steps to prevent Ukraine's military from using the Starlink satellite internet service for controlling drones in the region. Following the announcement, Ukrainian presidential advisor Mykhailo Podolyak said SpaceX needed to pick a side in the war against Russia. Ukrainian authorities worried about over-dependence on a single source technology held talks with other satellite internet providers. But they acknowledged none rival Starlink’s reach. “Starlink is indeed the blood of our entire communication infrastructure now,” Mykhailo Fedorov, Ukraine’s digital minister, told NYT. The technology, he said, enabled artillery teams, commanders and pilots to watch drone footage simultaneously while chatting online. According to soldiers, the response times from finding a target to hitting it have been cut to about a minute from nearly 20 minutes. “The huge number of lives that Starlink has helped save can be measured in the thousands,” Mr Fedorov added. “This is one of the fundamental components of our success." Mr Musk also asked the US last year to fund for their internet services to Ukraine because they could not continue the arrangement. The company estimated the cost at nearly $400m over 12 months, according to a SpaceX letter reported by CNN. About 1,300 Starlink terminals purchased through a British supplier stopped working last year after the Ukrainian government could not pay the $2,500 monthly fee for each, according to the report. Meanwhile, defence secretary Lloyd Austin in June approved a Pentagon deal to buy 400 to 500 new Starlink terminals and services, that would provide the Pentagon control of the setting where the internet signal worked inside Ukraine for new devices to carry out “key capabilities and certain missions”. The Independent has reached out to Space X for a comment. Read More Elon Musk’s Starlink satellites are leaking radiation that harms deep space astronomy, study warns 'X' logo installed atop Twitter building, spurring San Francisco to investigate permit violation Ukraine war – live: Putin’s aide says Russia ‘would be forced’ to go nuclear if Kyiv’s pushback is successful

NATO Secretary-General Jens Stoltenberg says representatives from Turkey and Sweden will meet in just over a week to try to bridge their differences about the Nordic country joining the military alliance

The U.N. Command says an American national has crossed the border from South Korea into North Korea

If it seems like lottery jackpots topping $1 billion are more common nowadays, it's because they are

About 100,000 New Yorkers live in basement homes that climate change has remade into "death traps".

A high-stakes lawsuit over the future of a widely used abortion drug is likely heading to the US Supreme Court, set to determine the fate of abortion rights access across the country for a second time within two years. Three Republican-appointed judges on a federal appeals court have determined that the federal government did not follow proper procedures when it amended regulations for a commonly used medication abortion drug in 2016. But the restrictions will not immediately take effect. The panel partially upheld a ruling from a Donald Trump-appointed federal judge in Texas, whose sweeping decision earlier this year threatened to strip access to the drug altogether. Nothing in the ruling from a three-judge panel on 16 August will go into effect until the nation’s highest court weighs in. Wednesday’s ruling argues that the US Food and Drug Administration unlawfully expanded access to mifepristone, which was first approved by the federal government more than 20 years ago. Mifepristone was first approved by the FDA in 2000 and is approved for use up to 10 weeks of pregnancy. A vast majority of abortions occur within the first nine weeks of pregnancy. From 2019 through 2020, nearly 93 per cent of all abortions were performed before the 13th week, according to the US Centers for Disease Control and Prevention. The drug – part of a two-drug protocol for medication abortions, the most common form of abortion care in the US – is the subject of a lawsuit from a group of anti-abortion activists represented by right-wing Christian legal group Alliance Defending Freedom, which joined efforts to overturn Roe v Wade at the Supreme Court last year. In April, US District Judge Matthew Kacsmaryk – a former right-wing activist lawyer who was appointed to the federal judiciary by Mr Trump – issued a ruling to suspend the FDA’s approval, which was immediately challenged by abortion rights advocates, providers, major medical groups, drug manufacturers and President Joe Biden’s administration. An initial ruling at the US Court of Appeals for the Fifth Circuit blocked part of that decision but struck down policies for mail-in prescriptions and rules that expanded the drug’s approval for pregnancies up to 10 weeks. On 21 April, the Supreme Court blocked the lower courts’ rulings from taking effect while the case plays out, retaining the status quo while the legal case plays out. Following the Supreme Court’s conservative supermajority decision to revoke a constitutional right to abortion care in Dobbs v Jackson Women’s Health Organization, at least 15 states – mostly across the US South – have effectively banned most abortions and imposed criminal penalties against providers. Abortion rights advocates and providers have warned that eliminating or restricting access to mifepristone could drastically impact an already-fragile landscape for abortion care. A ruling that undermines the FDA’s drug approval process could also open the door for other activist-driven legal battles over other drugs wrapped up in political debates, potentially inviting other destabilising lawsuits to Covid-19 vaccines, contraception, HIV medication, gender-affirming care, and other life-saving drugs. Read More What is mifepristone? The widely used pill in the abortion rights battle at the Supreme Court Abortion rights advocates win major victory in Ohio as voters reject GOP plan to thwart ballot measure Texas women detailed agonising pregnancies after being denied abortions. The state blames doctors Some abortion drug restrictions upheld by in a case bound for Supreme Court Akram criticizes Pakistan Cricket Board for leaving Imran Khan out of Independence Day video Netanyahu voices support for Israel's military after his allies and son lambaste security officials